Current Affairs Topics Archive
International Relations Economics Polity & Governance Environment & Ecology Science & Technology Internal Security Geography Social Issues Art & Culture Modern History

Unique Transaction Identifier for OTC Derivative Transactions


What Happened

  • The Reserve Bank of India issued notification RBI/2025-26/222 on 18 February 2026, mandating the use of a Unique Transaction Identifier (UTI) for all over-the-counter (OTC) derivative transactions reported to the CCIL Trade Repository.
  • The UTI framework will come into effect from 1 January 2027, applying to all transactions entered into on or after that date.
  • Covered instruments include Rupee interest rate derivatives, forward contracts in Government securities, foreign currency derivatives, foreign currency interest rate derivatives, and credit derivatives.
  • The UTI must conform to CPMI-IOSCO Technical Guidance (February 2017): a maximum of 52 alphanumeric characters comprising the Legal Entity Identifier (LEI) of the generating entity followed by a unique identifier, which must remain consistent throughout the transaction's lifecycle.
  • A "waterfall mechanism" has been prescribed to determine which counterparty generates the UTI; where a transaction is reported to the CCIL Trade Repository without a UTI, the CCIL-TR will generate one as fallback.
  • The directive is issued under Section 45W of the RBI Act, 1934, which empowers the RBI to issue directions to financial system participants for the orderly development and regulation of the financial system.

Static Topic Bridges

OTC Derivatives and Trade Reporting: Global Regulatory Context

Over-the-counter (OTC) derivatives are financial contracts negotiated directly between two parties (as opposed to exchange-traded derivatives), making them inherently opaque to regulators. The 2008 global financial crisis exposed the systemic risk concentrated in OTC derivative markets (particularly credit default swaps), prompting the G20 Pittsburgh Summit (2009) to mandate trade repository reporting for all OTC derivatives. This led to the creation of globally standardized identifiers — the Unique Transaction Identifier (UTI), Legal Entity Identifier (LEI), and Unique Product Identifier (UPI) — to enable regulators to aggregate exposures and detect systemic risks.

  • G20 Pittsburgh Summit mandate (2009): All OTC derivatives must be reported to Trade Repositories
  • CPMI-IOSCO Technical Guidance on UTI: Published February 2017 by the Bank for International Settlements (BIS)
  • UTI structure: Maximum 52 characters = LEI of generating entity + unique transaction code
  • UTI purpose: Uniquely identifies a single OTC derivative transaction through its entire lifecycle
  • Legal Entity Identifier (LEI): A 20-character global code identifying legal entities that engage in financial transactions
  • CCIL-TR (Clearing Corporation of India Limited – Trade Repository): India's designated trade repository for OTC derivatives

Connection to this news: RBI's February 2026 notification implements India's commitment to the G20/FSB framework by aligning domestic OTC derivative reporting with the internationally standardized UTI format prescribed by CPMI-IOSCO, making Indian derivative markets more transparent and globally interoperable.


RBI's Regulatory Framework for OTC Derivatives: Section 45W and CCIL

The Reserve Bank of India regulates OTC derivatives in India under Section 45W of the RBI Act, 1934, which empowers it to issue binding directions to participants in the money market, government securities market, and foreign exchange market. The Clearing Corporation of India Limited (CCIL) — established in 2001 — serves as India's central counterparty (CCP) and trade repository for OTC markets. CCIL's Trade Repository (CCIL-TR) is the single point of trade reporting for interest rate, government securities, foreign exchange, and credit derivatives in India. The UTI mandate reinforces CCIL-TR's role as the backbone of India's derivative market surveillance architecture.

  • Section 45W of the RBI Act, 1934: Empowers RBI to issue directions for OTC market development and regulation
  • CCIL established: 2001 (under RBI oversight)
  • CCIL functions: Central counterparty (CCP) for government securities, forex, and money market; Trade Repository
  • CCIL-TR role in UTI framework: Acts as fallback UTI generator when counterparties fail to provide one
  • UTI framework effective date: 1 January 2027
  • Operating guidelines to be issued by: CCIL (per RBI direction)

Connection to this news: The notification strengthens CCIL-TR's central role — it is not merely a passive data repository but an active participant in the UTI generation process, ensuring no transaction goes unidentified even in cases of counterparty non-compliance.


Financial Stability and Systemic Risk: Why OTC Derivative Transparency Matters

The 2008 financial crisis demonstrated how opaque OTC derivative exposures — particularly in credit default swaps — could create contagion risks that were invisible to regulators until systemic collapse was underway. The UTI framework is part of a broader post-crisis architecture (along with mandatory central clearing, margin requirements, and trade reporting) designed to give regulators real-time visibility into financial system-wide derivative exposures. For India, robust OTC derivative reporting is particularly relevant given the RBI's mandate for financial stability and India's growing integration into global capital markets under the Liberalised Remittance Scheme, foreign portfolio investment routes, and India's accession to global bond indices.

  • Post-2008 OTC derivative reforms globally mandated: Central clearing, trade reporting, margin requirements, UTI/LEI/UPI standardization
  • Financial Stability Board (FSB): Coordinates global implementation of OTC derivative reforms
  • India's OTC derivative market includes: Interest rate swaps, currency forwards, government securities forwards, credit default swaps
  • India joined JPMorgan GBI-EM bond index: June 2024 (signals growing global integration)
  • CPMI: Committee on Payments and Market Infrastructures (BIS body)
  • IOSCO: International Organisation of Securities Commissions

Connection to this news: The UTI mandate enhances India's OTC market transparency at a time when India's bond and derivative markets are increasingly integrated with global capital flows, reducing the information asymmetry that creates systemic risk.


Key Facts & Data

  • RBI notification: RBI/2025-26/222 dated 18 February 2026
  • Legal authority: Section 45W of the RBI Act, 1934
  • UTI effective date: 1 January 2027
  • UTI structure: Maximum 52 alphanumeric characters (LEI of generator + unique code)
  • Lifecycle tracking: UTI remains constant throughout a transaction's entire life
  • CPMI-IOSCO Technical Guidance on UTI: Published February 2017 (BIS)
  • Covered instruments: Rupee interest rate derivatives, G-Sec forward contracts, FX derivatives, FX interest rate derivatives, credit derivatives
  • Trade repository: CCIL-TR (Clearing Corporation of India Limited – Trade Repository)
  • Fallback UTI generator: CCIL-TR (if counterparties fail to submit UTI)
  • Waterfall mechanism: Prescribes hierarchy for UTI generation responsibility in both domestic and cross-border trades